Articles Archive - Healthed

Articles

Read the latest articles relevant to your clinical practice, including exclusive insights from Healthed surveys and polls.

By reading selected clinical articles, you earn CPD in the Educational Activities (EA) category whenever you click the “Claim CPD” button and follow the prompts.

Filter results

Policy, Women's health

Clinical Articles

Pharmacists in NSW can now initiate OCP scripts, VIC to follow

OCP resupply trial evaluation released as scope creep continues...

By Lynnette Hoffman

Drugs and devices

Clinical Articles

AZ pulling Zoladex 3.6mg from Australian market

Manufacturer will provide free access to eligible patients without alternative treatment pathways for 6 months after discontinuation...

By Lynnette Hoffman

Policy

Clinical Articles

Pharmacist-led care for UTIs trial evaluation released

Patients say it is convenient, but is it actually helping those who need it most?

By Lynnette Hoffman

Infectious diseases

Clinical Articles

Ebola may have spread beyond Africa. How are health authorities responding?

The latest Ebola outbreak is showing no signs of slowing.

By Healthed

Public health

Clinical Articles

Donations, access and secrecy: Three tactics tobacco companies use to influence smoking laws

Participating in regulatory review processes such as parliamentary inquiries isn’t the only way the tobacco industry tries to influence political decision-making. Tobacco companies deploy a number of strategies and interference techniques.

By Healthed

Policy

Clinical Articles

Inequality worsening under govt’s bulk billing policy – report

New incentive spending is helping the rich more and more and the poor less and less...

By Lynnette Hoffman

Public health

Clinical Articles

First Robodebt, now NDIS & aged care: How computers still decide who gets care

Algorithms deliver consistency, but at what cost?

By Healthed

Drugs and devices, Neurology

Clinical Articles

Cochrane finds Alzheimer’s drugs ineffective, as experts slam the review

Researchers analysed seven amyloid-busting monoclonal antibodies, concluding they don't work...

By Lynnette Hoffman

Public health

Clinical Articles

The TGA wants to overhaul sunscreen labels – and maybe even ditch SPF

A consultation is underway, here are the options being considered...

By Healthed

Policy

Clinical Articles

Tech giants face their ‘big tobacco’ moment

As US courts find Meta & YouTube liable for psychological harm, is the social media ban protecting young peoples' mental health here?

By Sophia Auld

Public health

Clinical Articles

We showed a 20% tax on junk food would save more lives than a sugar tax

New research suggests we could prevent millions of cases of T2D and CVD with this policy...

By Healthed

Art of medicine, Pharmacology

Clinical Articles

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes.

By Healthed

Pharmacists in NSW can now initiate OCP scripts, VIC to follow

OCP resupply trial evaluation released as scope creep continues...

By Lynnette Hoffman

Clinical Articles

Policy, Women's health

AZ pulling Zoladex 3.6mg from Australian market

Manufacturer will provide free access to eligible patients without alternative treatment pathways for 6 months after discontinuation...

By Lynnette Hoffman

Clinical Articles

Drugs and devices

Pharmacist-led care for UTIs trial evaluation released

Patients say it is convenient, but is it actually helping those who need it most?

By Lynnette Hoffman

Clinical Articles

Policy

Ebola may have spread beyond Africa. How are health authorities responding?

The latest Ebola outbreak is showing no signs of slowing.

By Healthed

Clinical Articles

Infectious diseases

Donations, access and secrecy: Three tactics tobacco companies use to influence smoking laws

Participating in regulatory review processes such as parliamentary inquiries isn’t the only way the tobacco industry tries to influence political decision-making. Tobacco companies deploy a number of strategies and interference techniques.

By Healthed

Clinical Articles

Public health

Inequality worsening under govt’s bulk billing policy – report

New incentive spending is helping the rich more and more and the poor less and less...

By Lynnette Hoffman

Clinical Articles

Policy

First Robodebt, now NDIS & aged care: How computers still decide who gets care

Algorithms deliver consistency, but at what cost?

By Healthed

Clinical Articles

Public health

Cochrane finds Alzheimer’s drugs ineffective, as experts slam the review

Researchers analysed seven amyloid-busting monoclonal antibodies, concluding they don't work...

By Lynnette Hoffman

Clinical Articles

Drugs and devices, Neurology

The TGA wants to overhaul sunscreen labels – and maybe even ditch SPF

A consultation is underway, here are the options being considered...

By Healthed

Clinical Articles

Public health

Tech giants face their ‘big tobacco’ moment

As US courts find Meta & YouTube liable for psychological harm, is the social media ban protecting young peoples' mental health here?

By Sophia Auld

Clinical Articles

Policy

We showed a 20% tax on junk food would save more lives than a sugar tax

New research suggests we could prevent millions of cases of T2D and CVD with this policy...

By Healthed

Clinical Articles

Public health

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes.

By Healthed

Clinical Articles

Art of medicine, Pharmacology

Articles

Filter results

OCP resupply trial evaluation released as scope creep continues...

Manufacturer will provide free access to eligible patients without alternative treatment pathways for 6 months after discontinuation...

Patients say it is convenient, but is it actually helping those who need it most?

The latest Ebola outbreak is showing no signs of slowing.

Participating in regulatory review processes such as parliamentary inquiries isn’t the only way the tobacco industry tries to influence political decision-making. Tobacco companies deploy a number of strategies and interference techniques.

New incentive spending is helping the rich more and more and the poor less and less...

Algorithms deliver consistency, but at what cost?

Researchers analysed seven amyloid-busting monoclonal antibodies, concluding they don't work...

A consultation is underway, here are the options being considered...

As US courts find Meta & YouTube liable for psychological harm, is the social media ban protecting young peoples' mental health here?

New research suggests we could prevent millions of cases of T2D and CVD with this policy...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes.

OCP resupply trial evaluation released as scope creep continues...

Manufacturer will provide free access to eligible patients without alternative treatment pathways for 6 months after discontinuation...

Patients say it is convenient, but is it actually helping those who need it most?

The latest Ebola outbreak is showing no signs of slowing.

Participating in regulatory review processes such as parliamentary inquiries isn’t the only way the tobacco industry tries to influence political decision-making. Tobacco companies deploy a number of strategies and interference techniques.

New incentive spending is helping the rich more and more and the poor less and less...

Algorithms deliver consistency, but at what cost?

Researchers analysed seven amyloid-busting monoclonal antibodies, concluding they don't work...

A consultation is underway, here are the options being considered...

As US courts find Meta & YouTube liable for psychological harm, is the social media ban protecting young peoples' mental health here?

New research suggests we could prevent millions of cases of T2D and CVD with this policy...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.